Abstract
The optimal extent of thyroidectomy for different thyroid diseases with surgical indications is controversial. Since the risk of reccurence for benign and malignant disease is a major consequence, more aggressive surgical management is believed to be warranted. Although there seems to be a strong selection bias in favor of the use of near-total and total thyroidectomy, more conservative approaches like subtotal or partial thyroidectomy have also been suggested for both benign / malignant conditions. ‘Which procedure, in which case’ has been a matter of debate. This debate is likely to continue. Advantages, disadvantages and the benefit-risk ratio have to be outweighed carefully. Herein, our objective was to find out the current place of the changing concepts of the extent of thyroidectomy in patients undergoing thyroid surgery.
Keywords:
Thyroidectomy, thyroid disease
References
1
Prinz RA. Difficult problems in thyroid surgery. Curr Probl Surg. 2002;39:1-92.
2
Kloos RT. Papillary thyroid cancer: medical management and follow-up. Curr Treat Options Oncol. 2005;6:323-38.
3
Boger MS, Perrier ND. Advantages and disadvantages of surgical therapy and optimal extent of thyroidectomy for the treatment of hyperthyroidism. Surg Clin North Am. 2004;84:849-74.
4
Dackiw AP, Zeiger M. Extent of surgery for differentiated thyroid cancer. Surg Clin North Am. 2004;84:817-32.
5
Kaplan EL. Thyroid and parathyroid. In: Principles of Surgery 6th ed 1996:p1611-80.
6
Guidelines for the management of thyroid cancer in adults. British Thyroid Association. Royal College of Physicians, London 2002:p24.
7
Wheeler MH. Investigation of the solitary thyroid nodule. Clin Endocrinol (Oxf). 1996;44:245-7.
8
Wadstrom C, Zedenius J, Guinea A, et al. Multinodular goitre presenting as a clinical single nodule: how effective is hemithyroidectomy? Aust N Z J Surg. 1999;69:34-6.
9
Delbridge L. Total thyroidectomy: the evolution of surgical technique. ANZ J Surg. 2003;73:761-8.
10
Rojdmark J, Jarhult J. High long term recurrence rate after subtotal thyroidectomy for nodular goitre. Eur J Surg. 1995;161:725-7[Abstract].
11
Marchesi M, Biffoni M, Faloci C, et al. High rate of recurrence after lobectomy for solitary thyroid nodule. Eur J Surg. 2002;168:397-400
12
Clark OH. What’s new in endocrine surgery. J Am Coll Surg. 1997;184:126-36.
13
Wheeler MH. Total thyroidectomy for benign thyroid disease. Lancet. 1998;351:1526-7.
14
Wong CK, Wheeler MH. Thyroid nodules: rational management. World J Surg. 2000;24:934-41.
15
Rodigas P, Sufian S, Kaibara N, et al. Surgery of the thyroid gland. Int Surg. 1977;62:588-91.
16
Scerrino G, Salamone G, Farulla MA, et al. Non-toxic multinodular goitre: which surgery? Ann Ital Chir. 2001;72:647-51.
17
Ozbas S, Kocak S, Aydintug S, et al. Comparison of the complications of subtotal, near total and total thyroidectomy in the surgical management of multinodular goitre. Endocr J. 2005;52:199-205.
18
Colak T, Akca T, Kanik A, et al. Total versus subtotal thyroidectomy for the management of benign multinodular goiter in an endemic region. ANZ J Surg. 2004;74:974-8.
19
Ayache S, Tramier B, Chatelain D, et al. Evolution of the thyroid surgical treatment to the total thyroidectomy. Study of about 735 patients. Ann Otolaryngol Chir Cervicofac. 2005;122:127-33.
20
Marchesi M, Biffoni M, Tartaglia F, et al. Total versus subtotal thyroidectomy in the management of multinodular goiter. Int Surg. 1998;83:202-4.
21
Ciuni S, Catalano F, Fimognari D, et al. Total versus subtotal thyroidectomy for multiple node goiter: experience with 350 surgically treated cases. G Chir. 2000;21:335-8[Abstract].
22
Uccheddu A, Cois A, Licheri S. The choice of the intervention in the surgical treatment of nontoxic diffuse multinodular goiter. Minerva Chir. 1996;51:25-32[Abstract].
23
Francomano F, Cotellese R, Scipione P, et al. Surgical treatment of hyperthyroidism. Ann Ital Chir. 1994;65:677-81[Abstract].
24
Thjodleifsson B, Hedley AJ, Donald D, et al. Outcome of sub-total thyroidectomy for thyrotoxicosis in Iceland and Northeast Scotland. Clin Endocrinol (Oxf). 1977;7:367-76.
25
Hermann M, Roka R, Richter B, et al. Early relapse after operation for Graves’ disease: postoperative hormone kinetics and outcome after subtotal, near-total, and total thyroidectomy. Surgery. 1998;124:894-900.
26
Dorairajan N, Ramkumar M, Kuruvila KT, et al. Total versus subtotal thyroidectomy in Grave’s disease: a retrospective analysis. Indian J Surg. 2002;64:506-10[Abstract].
27
Jarhult J, Rudberg C, Larsson E, et al. Graves’ disease with moderate-severe endocrine ophthalmopathy- long term results of a prospective, randomized study of total or subtotal thyroid resection. Thyroid. 2005;15:1157-64.
28
Witte J, Goretzki PE, Dotzenrath C, et al. Surgery for Graves’ disease: total versus subtotal thyroidectomy-results of a prospective randomized trial. World J Surg. 2000;24:1303-11.
29
Chi SY, Hsei KC, Sheen-Chen SM, et al. A prospective randomized comparison of bilateral subtotal thyroidectomy versus unilateral total and contralateral subtotal thyroidectomy for graves’ disease. World J Surg. 2005;29:160-3.
30
Palit TK, Miller CC 3rd, Miltenburg DM. The efficacy of thyroidectomy for Graves’ disease: A meta-analysis. J Surg Res. 2000;90:161-5.
31
Sugino K, Mimura T, Ozaki O, et al. Early recurrence of hyperthyroidism in patients with Graves’ disease treated by subtotal thyroidectomy. World J Surg. 1995;19:648-52
32
Takamura Y, Nakano K, Uruno T, et al. Changes in serum TSH receptor antibody (TRAb) values in patients with Graves’ disease after total or subtotal thyroidectomy. Endocr J. 2003;50:595-601
33
Kurihara H. Total thyroidectomy for the treatment of hyperthyroidism in patients with ophthalmopathy. Thyroid. 2002;12:265-7.
34
Weber KJ, Solorzano CC, Lee JK, et al. Thyroidectomy remains an effective treatment option for Graves’ disease. Am J Surg. 2006;191:400-5.
35
Bergamini C, Borrelli A, Reddavide S, et al. The results of total thyroidectomy in Basedow’s disease. The authors’ personal experience of 180 cases. G Chir. 2000;21:160-6.
36
Kebebew E, Clark OH. Differentiated thyroid cancer: “complete” rational approach. World J Surg. 2000;24:942-51.
37
Udelsman R, Chen H. The current management of thyroid cancer. Adv Surg. 1999;33:1-27.
38
Gimm O. Thyroid cancer. Cancer Lett. 2001;163:143-56[Abstract].
39
Shaha AR. Thyroid cancer: extent of thyroidectomy. Cancer Control. 2000;7:240-5.
40
Udelsman R, Shaha AR. Is total thyroidectomy the best possible surgical management for well-differentiated thyroid cancer? Lancet Oncol. 2005;6:529-31.
41
Haigh PI, Urbach DR, Rotstein LE. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer. Ann Surg Oncol. 2005;12:81-9.
42
Watkinson JC; British Thyroid Association. The British Thyroid Association guidelines for the management of thyroid cancer in adults. Nucl Med Commun. 2004;25:897-900.
43
Shigematsu N, Takami H, Ito N, et al. Nationwide survey on the treatment policy for well-differentiated thyroid cancer -- results of a questionnaire distributed at the 37th meeting of the Japanese Society of Thyroid Surgery. Endocr J. 2005 Aug;52(4):479-91.
